Surveillance, Epidemiology, and End Results Cancer Stat Facts: Myeloma. 2021. https://seer.cancer.gov/statfacts/html/mulmy.html.

Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2018, National Cancer Institute. Bethesda, MD, based on November 2020 SEER data submission, posted to the SEER web site, April 2021. https://seer.cancer.gov/csr/1975_2018/.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

Article  Google Scholar 

SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute. [Cited 2021 September 27]. 2021. https://seer.cancer.gov/explorer/.

Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351:1860–73.

CAS  Article  Google Scholar 

Landgren O, Shim YK, Michalek J, Costello R, Burton D, Ketchum N, et al. Agent orange exposure and monoclonal gammopathy of undetermined significance: An operation Ranch Hand Veteran Cohort Study. JAMA Oncol. 2015;1:1061–8.

Article  Google Scholar 

Pukkala E, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Tryggvadottir L, et al. Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occup Environ Med. 2014;71:398–404.

Article  Google Scholar 

Ruder AM, Hein MJ, Hopf NB, Waters MA. Mortality among 24,865 workers exposed to polychlorinated biphenyls (PCBs) in three electrical capacitor manufacturing plants: a ten-year update. Int J Hyg Environ Health. 2014;217:176–87.

CAS  Article  Google Scholar 

Landrigan PJ, Lioy PJ, Thurston G, Berkowitz G, Chen LC, Chillrud SN, et al. Health and environmental consequences of the world trade center disaster. Environ Health Perspect. 2004;112:731–9.

CAS  Article  Google Scholar 

Li J, Cone JE, Kahn AR, Brackbill RM, Farfel MR, Greene CM, et al. Association between World Trade Center exposure and excess cancer risk. JAMA. 2012;308:2479–88.

CAS  Article  Google Scholar 

Li J, Brackbill RM, Liao TS, Qiao B, Cone JE, Farfel MR, et al. Ten-year cancer incidence in rescue/recovery workers and civilians exposed to the September 11, 2001 terrorist attacks on the World Trade Center. Am J Ind Med. 2016;59:709–21.

Article  Google Scholar 

Zeig-Owens R, Webber MP, Hall CB, Schwartz T, Jaber N, Weakley J, et al. Early assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: an observational cohort study. Lancet. 2011;378:898–905.

Article  Google Scholar 

Li J, Yung J, Qiao B, Takemoto E, Goldfarb DG, Zeig-Owens R, et al. Cancer incidence in World Trade Center rescue and recovery workers: 14 years of follow-up. J Natl Cancer Inst. 2021;114:210–219.

Shapiro MZ, Wallenstein SR, Dasaro CR, Lucchini RG, Sacks HS, Teitelbaum SL, et al. Cancer in general responders participating in World Trade Center Health Programs, 2003–2013. JNCI Cancer Spectr. 2020;4:pkz090.

Article  Google Scholar 

Moline JM, Herbert R, Crowley L, Troy K, Hodgman E, Shukla G, et al. Multiple myeloma in World Trade Center responders: A case series. J Occup Environ Med. 2009;51:896–902.

Article  Google Scholar 

Landgren O, Zeig-Owens R, Giricz O, Goldfarb D, Murata K, Thoren K, et al. Multiple myeloma and its precursor disease among firefighters exposed to the World Trade Center disaster. JAMA Oncol. 2018;4:821–7.

Article  Google Scholar 

Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ 3rd, Colby CL, et al. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet. 2010;375:1721–8.

Article  Google Scholar 

Dasaro CR, Holden WL, Berman KD, Crane MA, Kaplan JR, Lucchini RG, et al. Cohort profile: World Trade Center Health Program general responder cohort. Int J Epidemiol. 2017;46:e9.

Article  Google Scholar 

Hutchison CA, Landgren O. Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation. Clin Chem. 2011;57:1387–9.

CAS  Article  Google Scholar 

Korde N, Kristinsson SY, Landgren O. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): Novel biological insights and development of early treatment strategies. Blood. 2011;117:5573–81.

CAS  Article  Google Scholar 

Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA, et al. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood. 2009;113:6386–91.

CAS  Article  Google Scholar 

Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002;48:1437–44.

CAS  Article  Google Scholar 

Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362–9.

CAS  Article  Google Scholar 

Yip J, Webber MP, Zeig-Owens R, Vossbrinck M, Singh A, Kelly K, et al. FDNY and 9/11: Clinical services and health outcomes in World Trade Center-exposed firefighters and EMS workers from 2001 to 2016. Am J Ind Med. 2016;59:695–708.

Article  Google Scholar 

Prezant DJ, Weiden M, Banauch GI, McGuinness G, Rom WN, Aldrich TK, et al. Cough and bronchial responsiveness in firefighters at the World Trade Center site. N Engl J Med. 2002;347:806–15.

Article  Google Scholar 

Zeig-Owens R, Kablanian A, Webber MP, Liu Y, Mayerson E, Schwartz T, et al. Agreement between self-reported and confirmed cancer diagnoses in New York City firefighters and EMS workers, 2001–2011. Public Health Rep. 2016;131:153–9.

Article  Google Scholar 

Castaneda-Avila MA, Ulbricht CM, Epstein MM. Risk factors for monoclonal gammopathy of undetermined significance: A systematic review. Ann Hematol. 2021;100:855–63.

Article  Google Scholar 

Landgren O, Graubard BI, Katzmann JA, Kyle RA, Ahmadizadeh I, Clark R, et al. Racial disparities in the prevalence of monoclonal gammopathies: A population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 2014;28:1537–42.

CAS  Article  Google Scholar 

Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics. 1985;41:55–68.

CAS  Article  Google Scholar 

Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564–9.

Article  Google Scholar 

Goldfarb DG, Zeig-Owens R, Kristjansson D, Li J, Brackbill RM, Farfel MR, et al. Cancer survival among World Trade Center rescue and recovery workers: A collaborative cohort study. Am J Ind Med. 2021;64:815–26.

Article  Google Scholar 

Rognvaldsson S, Love TJ, Thorsteinsdottir S, Reed ER, Oskarsson J, Petursdottir I. et al. Iceland screens, treats, or prevents multiple myeloma (iStopMM): A population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood Cancer J. 2021;11:94.

Article  Google Scholar